A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: Outcome at 30-month follow-up

Schizophrenia Bulletin

Volumn 39, Issue 2, 2013, Pages 436-448

  Gleeson, John F M ^a   Cotton, Sue M ^b   Alvarez Jimenez, Mario ^b   Wade, Darryl ^c   Gee, Donna ^d   Crisp, Kingsley ^d   Pearce, Tracey ^d   Spiliotacopoulos, Daniela ^b   Newman, Belinda ^b   McGorry, Patrick D ^b  

^a AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

early psychosis; first episode psychosis; randomized controlled trials; relapse prevention

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RELAPSE PREVENTION THERAPY; REMISSION; SOCIAL PSYCHOLOGY; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; FAMILY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; PSYCHOTIC DISORDERS; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874549237     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbr165     Document Type: Article

References (40)

1. McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry. 2008;7:148-156.
2. Bertelsen M, Jeppesen P, Petersen L, et al. Five-year followup of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry. 2008;65:762-771. (Pubitemid 351957702)
3. Addington D, Addington MDJ, Patten S. Relapse rates in an early psychosis treatment service. Acta Psychiatr Scand. 2007;115:126-131. (Pubitemid 46114873)
4. Ascher-Svanum H, Zhu BJ, Faries DE, et al. The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry. 2010;10:2.
5. Alvarez-Jimenez M, Parker AG, Hetrick SE, McGorry PD, Gleeson JF. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull. 2011;37: 619-630.
6. Gleeson JF, Alvarez-Jimenez M, Cotton SM, Parker AG, Hetrick S. A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis. Schizophr Res. 2010;119:79-88.
7. Cassidy CM, Rabinovitch M, Schmitz N, Joober R, Malla A. A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. J Clin Psychopharmacol. 2010;30:64-67.
8. Patel J, Buckley P, Woolson S, et al. Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. Schizophr Res. 2009;111:9-16.
9. Gleeson JF, Cotton SM, Alvarez-Jimenez M, et al. A randomized controlled trial of relapse prevention therapy for firstepisode psychosis patients. J Clin Psychiatry. 2009;70:477-486.
10. Gleeson JF, Cotton SM, Alvarez-Jimenez M, et al. Family outcomes froma randomized control trial of relapse prevention therapy in first-episode psychosis. JClin Psychiatry. 2010;71:475-483.
11. APA. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
12. Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull. 1986;12:578-593.
13. Alvarez-Jimenez M, Wade D, Cotton S, et al. Enhancing treatment fidelity in psychotherapy research: novel approach to measure the components of cognitive behavioural therapy for relapse prevention in first-episode psychosis. Aust N Z J Psychiatry. 2008;42:1013-1020.
14. Early Psychosis Prevention and Intervention Centre.Case Management in Early Psychosis: A Handbook Parkville, Victoria, Australia: EPPIC; 2001.
15. Falloon I. Handbook of Behavioral Family Therapy. New York, NY: Guilford Press.
16. Linszen D, Dingemans P, Van der Does JW, et al. Treatment, expressed emotion and relapse in recent onset schizophrenic disorders. Psychol Med. 1996;26:333-342. (Pubitemid 26075206)
17. Early Psychosis Guidelines Writing Group. Australian Clinical Guidelines for Early Psychosis. 2 ed. Melbourne, Australia: Orygen Youth Health; 2010.
18. McGorry P, Killackey E, Lambert T, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry. 2005;39:1-30. (Pubitemid 40282556)
19. Ventura J, Liberman RP, Green MF, Shaner A,Mintz J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res. 1998;79:163-173. (Pubitemid 28308489)
20. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) User's guide and Interview. Washington, DC: American Psychiatric Press; 1997.
21. Montgomery SM. Depressive symptoms in acute schizophrenia. Prog Neuropsychopharmacol. 1979;3:429-433. (Pubitemid 10158397)
22. Andreasen NC. Scale for Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa; 1984.
23. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry. 1993;150:873-879. (Pubitemid 23156765)
24. Thompson K, Kulkarni J, Sergejew A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42:241-247. (Pubitemid 30216535)
25. Lambert TJR, Cock N, Alcock SJ, Kelly DL, Conley RR. Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Hum Psychopharmacol. 2003;18:405-411. (Pubitemid 36896427)
26. Ginsberg JP. Wechsler test of adult reading. Appl Neuropsychol. 2003;10:182-184.
27. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8:470-484.
28. Goldman HH, Skodol AE, Lave TR. Revising Axis-V for DSM-IV-a review of measures of social functioning. Am J Psychiatry. 1992;149:1148-1156.
29. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551-558.
30. Ali R, Awwad E, Babor T, et al. The Alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97: 1183-1194.
31. Gossop M, Darke S, Griffiths P, et al. The severity of dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607-614.
32. Ventura J, Nuechterlein KH, Hardesty JP, Gitlin M. Life events and schizophrenic relapse after withdrawal of medication. Br J Psychiatry. 1992;161:615-620.
33. Gueorguieva R, Krystal J. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61:310-331.
34. Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med. 2002;32:763-782. (Pubitemid 34823330)
35. Gumley A, O'GradyM,McNay L, Reilly J, Power K, Norrie J. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med. 2003;33:419-431. (Pubitemid 36442785)
36. Jackson H, McGorry P, Edwards J, et al. A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four-year follow-up readmission data. Psychol Med. 2005;35:1295-1306. (Pubitemid 41264309)
37. Lilienfeld S. Psychological treatments that cause harm. Perspect Psychol Sci. 2007;2:53-70.
38. Gumley A, White C, Power K. An interacting cognitive subsystems model of relapse and the course of psychosis. Clin Psychol Psychother. 1999;6:261-278.
39. Johnstone EC, Macmillan JF, Frith CD, Benn DK, Crow TJ. Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry. 1990;157: 182-189. (Pubitemid 20241169)
40. Fialko L, Garety PA, Kuipers E, et al. A large-scale validation study of the medication adherence rating scale (MARS). Schizophr Res. 2008;100:53-59.